3378 Share Price Performance
HK$24.16
6.96 (40.47%)
Price HK$24.16
Share Pricen/a
No recently updated narratives available.
Hanx Biopharmaceuticals (Wuhan) Co., Ltd. develops and manufactures immunotherapies for cancer and autoimmune diseases. The company's products include antibody drugs, including monoclonal, bispecific, and antibody drug conjugates for immuno-oncology pathways. The company was incorporated in 2014 and is headquartered in Wuhan, China.